These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Modelling the strategies for age specific vaccination scheduling during influenza pandemic outbreaks. Knipl DH; Röst G Math Biosci Eng; 2011 Jan; 8(1):123-39. PubMed ID: 21361404 [TBL] [Abstract][Full Text] [Related]
45. Adaptation of pandemic H2N2 influenza A viruses in humans. Joseph U; Linster M; Suzuki Y; Krauss S; Halpin RA; Vijaykrishna D; Fabrizio TP; Bestebroer TM; Maurer-Stroh S; Webby RJ; Wentworth DE; Fouchier RA; Bahl J; Smith GJ; J Virol; 2015 Feb; 89(4):2442-7. PubMed ID: 25505070 [TBL] [Abstract][Full Text] [Related]
46. Confronting the next pandemic--workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27-29, 2010. Hardy S; Eichelberger M; Griffiths E; Weir JP; Wood D; Alfonso C Influenza Other Respir Viruses; 2011 Nov; 5(6):438-42. PubMed ID: 21668676 [No Abstract] [Full Text] [Related]
48. Pre-pandemic and pandemic influenza vaccines. Rockman S; Brown L Hum Vaccin; 2010 Oct; 6(10):792-801. PubMed ID: 20935469 [TBL] [Abstract][Full Text] [Related]
49. Start of the influenza season 2010-11 in Europe dominated by 2009 pandemic influenza A(H1N1) virus. Influenza Team Euro Surveill; 2010 Dec; 15(50):. PubMed ID: 21172169 [No Abstract] [Full Text] [Related]
50. Pandemic influenza vaccination during pregnancy: an investigation of vaccine uptake during the 2009/10 pandemic vaccination campaign in Great Britain. Sammon CJ; McGrogan A; Snowball J; de Vries CS Hum Vaccin Immunother; 2013 Apr; 9(4):917-23. PubMed ID: 23364304 [TBL] [Abstract][Full Text] [Related]
51. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness. Wkly Epidemiol Rec; 2012 Oct; 87(42):401-12. PubMed ID: 23113329 [No Abstract] [Full Text] [Related]
52. Flu: vaccinate to cut risk of chimaeric virus emerging. Capua I; Cattoli G Nature; 2009 Jul; 460(7255):571. PubMed ID: 19641576 [No Abstract] [Full Text] [Related]
53. One health approach to influenza: assessment of critical issues and options. Powdrill TF; Nipp TL; Rinderknecht JL Emerg Infect Dis; 2010 Aug; 16(8):e1. PubMed ID: 20678310 [TBL] [Abstract][Full Text] [Related]
54. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection. Schmidt T; Dirks J; Enders M; Gärtner BC; Uhlmann-Schiffler H; Sester U; Sester M Eur J Immunol; 2012 Jul; 42(7):1755-66. PubMed ID: 22585549 [TBL] [Abstract][Full Text] [Related]
55. Effectiveness of seasonal 2010/11 and pandemic influenza A(H1N1)2009 vaccines in preventing influenza infection in the United Kingdom: mid-season analysis 2010/11. Pebody R; Hardelid P; Fleming D; McMenamin J; Andrews N; Robertson C; Thomas D; Sebastianpillai P; Ellis J; Carman W; Wreghitt T; Zambon M; Watson J Euro Surveill; 2011 Feb; 16(6):. PubMed ID: 21329644 [TBL] [Abstract][Full Text] [Related]
56. How did the 2008-2009 seasonal influenza vaccine affect the pandemic? Glezen WP Clin Infect Dis; 2010 Dec; 51(12):1380-2. PubMed ID: 21067354 [No Abstract] [Full Text] [Related]
58. Influenza virus vaccines: lessons from the 2009 H1N1 pandemic. Broadbent AJ; Subbarao K Curr Opin Virol; 2011 Oct; 1(4):254-62. PubMed ID: 22125588 [TBL] [Abstract][Full Text] [Related]
59. Incorporating research and evaluation into pandemic influenza vaccination preparedness and response. Shimabukuro TT; Redd SC Emerg Infect Dis; 2014 Apr; 20(4):713-714. PubMed ID: 24795933 [No Abstract] [Full Text] [Related]
60. Combining estimates from two surveys: an example from monitoring 2009 influenza A (H1N1) pandemic vaccination. Furlow-Parmley C; Singleton JA; Bardenheier B; Bryan L Stat Med; 2012 Nov; 31(27):3285-94. PubMed ID: 22859268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]